The In2Care® Mosquito Trap is a unique mosquito control product that attracts mosquitoes ready to lay eggs and uses novel and green alternatives to insecticides to kill them. It exploits the concept of “autodissemination”contaminating mosquitoes with larvicide powder and using them to spread this killing agent to surrounding breeding sites. This is particularly effective for container-breeding and skip-ovipositing Aedes mosquitoes that can transmit Dengue and Chikungunya virus.

The trap is made of durable and recycled polyethylene and contains a floater that moves along with the water level and serves as the landing/resting site for mosquitoes. Gravid female mosquitoes are attracted to the trap by the attractive odours added to the water reservoir, and land on the floater gauze containing the bio-actives. These bio-actives target not only the mosquito (killing these within 10 days) and its larvae, but also the Dengue virus inside the mosquito. The unique mixture provides an environmentally-friendly alternative to synthetic pesticides and combines active ingredients that individually are used in other mosquito products which are WHO recommended and/or US-EPA approved. Trap impacts have been demonstrated and published in a peer-reviewed scientific journal.

Active ingredients in the trap need to be replaced and water replenished every 6-8 weeks. Area-wide coverage of at least 1 trap per 400 m2 is needed to ensure a significant impact on Aedes mosquito populations. The In2Care® Mosquito Trap lends itself perfectly for use by pest control companies that offer mosquito control services to resorts, hotels, restaurants, etc. It provides a low-cost tool to target Aedes mosquitoes and prevent outbreaks of Dengue and Chikungunya in a smart way with minimised effort throughout the year.

SIM-22 - Muggenval versie 2 131002 Componenten

An extensive dossier about the In2Care Mosquito trap is currently being examined by the World Health Organization’s Vector Control Advisory Group (WHO-VCAG). The VCAG published its annual report in October 2014 which included an evaluation of the supporting evidence for the In2Care Mosquito Trap. The report stated that “The combination of attractive ovitrap with slow-acting, non-chemical adulticides (one of which alters virus replication dynamics) allowing dissemination by mosquitoes of a growth regulator meets the criteria for a new paradigm” 

UA-22190788-1